Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Selinski

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Toxicology and Environmental Health. Part A|June 13, 2012
Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industryDaniel Ovsiannikov, Silvia Selinski, Marie-Louise Lehmann, et al.
Journal of Toxicology and Environmental Health. Part A|December 8, 2016
Occupational risk factors for relapse-free survival in bladder cancer patientsSilvia Selinski, Hannah Bürger, Meinolf Blaszkewicz, et al.
Investigative and Clinical Urology|May 8, 2020
Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancerHui-Juan Huang-Tiel, Isabella Otto, Klaus Golka, et al.
Archives of Toxicology|March 8, 2011
Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs"Klaus Golka, Silvia Selinski, Marie-Louise Lehmann, et al.
International Journal of Molecular Sciences|November 12, 2016
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate CancerThorsten H Ecke, Hui-Juan Huang-Tiel, Klaus Golka, et al.
Pharmacogenetics and Genomics|October 6, 2009
Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposureKlaus Golka, Matthias Hermes, Silvia Selinski, et al.
Archives of Toxicology|November 8, 2008
Synergism of aromatic amines and benzo[a]pyrene in induction of Ah receptor-dependent genesAlexandra Borza, Sabine Plöttner, Alexander Wolf, et al.
Journal of Toxicology and Environmental Health. Part A|June 24, 2008
The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancerKlaus Golka, Tobias Schmidt, Thilo Seidel, et al.
Journal of Toxicology and Environmental Health. Part A|July 12, 2017
Urinary cadmium levels in active and retired coal minersJulia Isermann, Hans-Martin Prager, Rainer Ebbinghaus, et al.
Advances in Therapy|February 25, 2017
Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3Holger Gerullis, Dimitri Barski, Evangelos Georgas, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Toxicology and Environmental Health. Part A|June 13, 2012
Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industryDaniel Ovsiannikov, Silvia Selinski, Marie-Louise Lehmann, et al.
Journal of Toxicology and Environmental Health. Part A|December 8, 2016
Occupational risk factors for relapse-free survival in bladder cancer patientsSilvia Selinski, Hannah Bürger, Meinolf Blaszkewicz, et al.
Investigative and Clinical Urology|May 8, 2020
Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancerHui-Juan Huang-Tiel, Isabella Otto, Klaus Golka, et al.
Archives of Toxicology|March 8, 2011
Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs"Klaus Golka, Silvia Selinski, Marie-Louise Lehmann, et al.
International Journal of Molecular Sciences|November 12, 2016
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate CancerThorsten H Ecke, Hui-Juan Huang-Tiel, Klaus Golka, et al.
Pharmacogenetics and Genomics|October 6, 2009
Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposureKlaus Golka, Matthias Hermes, Silvia Selinski, et al.
Archives of Toxicology|November 8, 2008
Synergism of aromatic amines and benzo[a]pyrene in induction of Ah receptor-dependent genesAlexandra Borza, Sabine Plöttner, Alexander Wolf, et al.
Journal of Toxicology and Environmental Health. Part A|June 24, 2008
The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancerKlaus Golka, Tobias Schmidt, Thilo Seidel, et al.
Journal of Toxicology and Environmental Health. Part A|July 12, 2017
Urinary cadmium levels in active and retired coal minersJulia Isermann, Hans-Martin Prager, Rainer Ebbinghaus, et al.
Advances in Therapy|February 25, 2017
Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3Holger Gerullis, Dimitri Barski, Evangelos Georgas, et al.
Pageof 6